A Pharmacokinetic Study of VCT220 in Particicants With Hepatic Injury and Normal Hepatic Function

NCT06938529 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity, Overweight

Interventions

DRUG: VCT220
DRUG: Placebo

Sponsor

Vincentage Pharma Co., Ltd